Physician profile
Anthony Robles Wright
NPI 1295300580
$3,317.06
in general payments reported to CMS, 2019-2025
10 companies · $2,859 in 2025
The $2,859 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $79.08 · 2024: $379 · 2025: $2,859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,990 · Travel and Lodging: $1,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,989.52 |
| Travel and Lodging | $1,327.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,181.30 | 2025 | |
| Smith+Nephew, INC. | $550.68 | 2023-2025 | Stravix, Evos, Panta 2 |
| Integra Lifesciences Corporation | $412.61 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medline Industries Lp | $358.39 | 2025 | |
| Orthofix Medical, INC. | $221.65 | 2025 | Truelok |
| Paragon 28, INC. | $140.13 | 2025 | Portfolio |
| Polynovo North America LLC | $136.40 | 2025 | Novosorb Btm |
| Bone Support INC. | $135.08 | 2025 | Cerament G, Ceramentbone Void Filler |
| Mimedx Group, INC. | $124.48 | 2025 | |
| Stryker Corporation | $56.34 | 2025 | T2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.